Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
Johira, Yusuke, Nakahara, Takashi, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Kawaoka, Tomokazu, Hayes, C Nelson, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Published in BMC gastroenterology (28.06.2023)
Published in BMC gastroenterology (28.06.2023)
Get full text
Journal Article
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein
Kinami, Takahiro, Amioka, Kei, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Published in Cancers (01.04.2023)
Published in Cancers (01.04.2023)
Get full text
Journal Article
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
Kinami, Takahiro, Uchikawa, Shinsuke, Kawaoka, Tomokazu, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Yamaoka, Kenji, Fujii, Yasutoshi, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Tsuge, Masataka, Oka, Shiro
Published in Cancer medicine (Malden, MA) (01.03.2024)
Published in Cancer medicine (Malden, MA) (01.03.2024)
Get full text
Journal Article
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target Lesions
Yano, Shigeki, Kimura, Tomoki, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Johira, Yusuke, Kosaka, Masanari, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Hirokawa, Junichi, Nagata, Yasushi, Aikata, Hiroshi, Oka, Shiro
Published in Cancers (30.01.2023)
Published in Cancers (30.01.2023)
Get full text
Journal Article
Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
Amioka, Kei, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ono, Atsushi, Yamauchi, Masami, Imamura, Michio, Kosaka, Yumi, Ohya, Kazuki, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Masaki, Keiichi, Honda, Yoji, Kouno, Hirotaka, Kohno, Hioshi, Morio, Kei, Moriya, Takashi, Naeshiro, Noriaki, Nonaka, Michihiro, Aisaka, Yasuyuki, Azakami, Takahiro, Hiramatsu, Akira, Aikata, Hiroshi, Oka, Shiro
Published in Cancers (01.10.2022)
Published in Cancers (01.10.2022)
Get full text
Journal Article
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
Kikugawa, Chihiro, Uchikawa, Shinsuke, Kawaoka, Tomokazu, Kinami, Takahiro, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Tsuge, Masataka, Kosaka, Yumi, Ohya, Kazuki, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Kouno, Hirotaka, Kohno, Hiroshi, Morio, Kei, Moriya, Takashi, Nonaka, Michihiro, Aisaka, Yasuyuki, Masaki, Keiichi, Honda, Yohji, Naeshiro, Noriaki, Hiramatsu, Akira, Aikata, Hiroshi, Oka, Shiro
Published in Oncology (01.03.2024)
Published in Oncology (01.03.2024)
Get more information
Journal Article
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib
Chihiro, Kikukawa, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Teraoka, Yuji, Uchida, Takuro, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Published in Oncology (01.08.2023)
Published in Oncology (01.08.2023)
Get more information
Journal Article